SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-115103
Filing Date
2022-04-22
Accepted
2022-04-22 16:06:53
Documents
5
Period of Report
2022-04-22

Document Format Files

Seq Description Document Type Size
1 6-K d336386d6k.htm 6-K 13667
2 EX-1.1 d336386dex11.htm EX-1.1 215868
3 EX-5.1 d336386dex51.htm EX-5.1 47083
4 GRAPHIC g336386a0002.jpg GRAPHIC 9094
5 GRAPHIC g336386g0421091950731.jpg GRAPHIC 3109
  Complete submission text file 0001193125-22-115103.txt   294866
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 22845518
SIC: 2834 Pharmaceutical Preparations